Industry Experts

Rajakumar Mandraju is an accomplished immunologist with deep expertise in cellular and molecular immunology, focusing on immune responses to gene therapies. As Director of Immunology at Modalis Therapeutics, he leads efforts to assess and mitigate immunogenicity, develop immune tolerance strategies, and guide preclinical and translational studies for AAV-based in-vivo gene therapies. With over 15 years spanning academia and industry, his work has advanced understanding of T cell biology, innate-adaptive crosstalk, and immunomodulatory approaches in rare diseases, autoimmunity and oncology. A recognized contributor to immunology literature, he actively participates in AAI, CIS, and ASGCT, and holds a Ph.D. in Biochemistry from the University of Hyderabad.